Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
electroCore | ECOR | Nov 22, 2024 | 11.21 | +13.00 |
Electromed | ELMD | Nov 22, 2024 | 29.79 | +6.13 |
Electronic Arts | EA | Nov 22, 2024 | 166.67 | -0.77 |
Electrovaya | ELVA | Nov 22, 2024 | 2.36 | +1.72 |
Eledon Pharmaceuticals | ELDN | Nov 22, 2024 | 4.01 | -1.47 |
Element Solutions | ESI | Nov 22, 2024 | 29.04 | +1.68 |
Elevai Labs | ELAB | Nov 22, 2024 | 0.02 | -0.50 |
Elevance Health | ELV | Nov 22, 2024 | 402.55 | -0.26 |
Elevation Oncology | ELEV | Nov 22, 2024 | 0.60 | -0.30 |
Eli Lilly | LLY | Nov 22, 2024 | 748.01 | -0.25 |
Elicio Therapeutics | ELTX | Nov 22, 2024 | 4.93 | -3.71 |
Eliem Therapeutics | ELYM | Nov 22, 2024 | 5.11 | 0.00 |
Ellington Financial | EFC-B | Nov 22, 2024 | 23.10 | +0.04 |
Ellington Financial | EFC | Nov 22, 2024 | 12.52 | +0.97 |
Ellington Financial A Pref | EFC-A | Nov 22, 2024 | 25.29 | +0.06 |
Ellington Financial D Pref | EFC-D | Nov 22, 2024 | 22.87 | +0.25 |
Ellington Financial E Pref | EFC-E | Nov 22, 2024 | 25.45 | -0.10 |
Ellington Financial Pref | EFC-C | Nov 22, 2024 | 25.25 | +0.68 |
Ellington Residential Mortgage REIT | EARN | Nov 22, 2024 | 6.76 | +1.65 |
Ellomay Capital | ELLO | Nov 22, 2024 | 16.02 | -3.49 |
Ellsworth Growth | ECF | Nov 22, 2024 | 9.72 | -0.82 |
Ellsworth Growth A | ECF-A | Nov 22, 2024 | 23.38 | +1.21 |
Elme Communities | ELME | Nov 22, 2024 | 16.16 | +1.83 |
Eltek | ELTK | Nov 22, 2024 | 11.05 | +1.10 |
Elutia | ELUT | Nov 22, 2024 | 4.12 | -6.36 |
Embecta | EMBC | Nov 22, 2024 | 13.82 | -1.29 |
Embotelladora Andina ADR | AKO-B | Nov 22, 2024 | 17.66 | -0.14 |
Embotelladora Andina ADR | AKO-A | Nov 22, 2024 | 13.10 | -0.61 |
Embrace Change Acquisition | EMCG | Nov 22, 2024 | 11.65 | +0.09 |
Embrace Change Acquisition Unit | EMCGU | Nov 22, 2024 | 11.65 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.